Is vascular endothelial growth factor (VEGF) the main mediator in ovarian hyperstimulation syndrome (OHSS)?

被引：15
|
作者：
Ajonuma, Louis Chukwuemeka [1 ]
机构：
[1] St Marys Matern Hosp, Etiti, Imo State, Nigeria
来源：
MEDICAL HYPOTHESES | 2008年 / 70卷 / 06期
关键词：
D O I：
10.1016/j.mehy.2007.11.004
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Ovarian hyperstimulation syndrome (OHSS) remains one of the most life-threatening and potentially fatal complications of assisted reproduction treatments (ART), due to excessive stimulation of the ovaries by exogenously administrated gonadotropins. The pathogenesis of OHSS remains obscure and patient treatments are empirical. However, vascular endothelial growth factor (VEGF) has been suggested to be responsible for OHSS. The present hypothesis aims to discuss the possible role of epithelial ion channels particularly cystic fibrosis transmembrane conductance regulator (CFTR) involvement in the pathogenesis of OHSS. This may provide grounds for the development of a better treatment strategy to reduce the risk of OHSS and improve in vitro fertilization (IVF) outcome. (C) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码：1174 / 1178
页数：5
相关论文
共 50 条
  • [31] Ovarian hyperstimulation syndrome (OHSS): diagnosis and management
    Myrianthefs, P
    Ladakis, C
    Lappas, V
    Pactitis, S
    Carouzou, A
    Fildisis, G
    Baltopoulos, G
    INTENSIVE CARE MEDICINE, 2000, 26 (05) : 631 - 634
  • [32] Increased risk of ovarian hyperstimulation syndrome following controlled ovarian hyperstimulation in patients with vascular endothelial growth factor+405 cc genotype
    Hanevik, Hans Ivar
    Hilmarsen, Hilde Tveitan
    Skjelbred, Camilla Furu
    Tanbo, Tom
    Kahn, Jarl A.
    GYNECOLOGICAL ENDOCRINOLOGY, 2012, 28 (11) : 845 - 849
  • [33] Re: Ovarian hyperstimulation syndrome (OHSS) reply
    Mathur, Raj
    Prakash, Alka
    OBSTETRICIAN & GYNAECOLOGIST, 2013, 15 (03): : 207 - 207
  • [34] Ovarian hyperstimulation syndrome (OHSS) at a maternity hospital
    V Lappas
    P Myrianthefs
    C Ladakis
    S Pactitis
    A Carousou
    J Stamatiou
    G Baltopoulos
    Critical Care, 3 (Suppl 1):
  • [35] Serum concentration of vascular endothelial growth factor cannot predict the course of severe ovarian hyperstimulation syndrome
    Ludwig, M
    Bauer, O
    Lopens, A
    Jelkmann, W
    Diedrich, K
    HUMAN REPRODUCTION, 1998, 13 (01) : 30 - 32
  • [36] Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome
    Abramov, Y
    Barak, V
    Nisman, B
    Schenker, JG
    FERTILITY AND STERILITY, 1997, 67 (02) : 261 - 265
  • [37] Prediction and prevention of ovarian hyperstimulation syndrome (OHSS)
    Zouves, C
    Sher, G
    Sohn, S
    Barnes, F
    Maassarani, G
    Feinman, M
    IN VITRO FERTILIZATION AND ASSISTED REPRODUCTION, 1997, : 445 - 451
  • [38] COMPLEMENT ACTIVATION IN OVARIAN HYPERSTIMULATION SYNDROME (OHSS)
    ENSKOG, A
    UNANDER, AM
    NILSSON, L
    HAEGER, M
    BENGTSSON, A
    JOURNAL OF IMMUNOLOGY, 1993, 150 (08): : A216 - A216
  • [39] Ovarian hyperstimulation syndrome (OHSS): diagnosis and management
    P. Myrianthefs
    C. Ladakis
    V. Lappas
    S. Pactitis
    A. Carouzou
    G. Fildisis
    G. Baltopoulos
    Intensive Care Medicine, 2000, 26 : 631 - 634
  • [40] Predictive Value of Serum Vascular Endothelial Growth Factor and Pigment Epithelium-derived Factor in Ovarian Hyperstimulation Syndrome
    Wei ZHANG 1
    Journal of Reproduction and Contraception, 2012, (03) : 141 - 149
12345